Industry / China
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Sinovac's H5N1 Flu Vaccine Approved By SFDA
April 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Chinese biopharmaceutical company Sinovac (Beijing Kexing Bioproducts) has received State Food and Drug Administration (SFDA) approval for production of its whole-viron inactivated H5N1 vaccine, Panflu. In a major coup for the local vaccine-developer, the vaccine will be the first and only vaccine against human H5N1 influenza licensed in